scholarly journals Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells

2019 ◽  
Vol 10 (6) ◽  
Author(s):  
Benardina Ndreshkjana ◽  
Aysun Çapci ◽  
Volker Klein ◽  
Pithi Chanvorachote ◽  
Julienne K. Muenzner ◽  
...  
2012 ◽  
Vol 39 (9) ◽  
pp. 8717-8722 ◽  
Author(s):  
Chen Liu ◽  
Hongpeng Xue ◽  
Yixia Lu ◽  
Baorong Chi

Cancers ◽  
2019 ◽  
Vol 11 (10) ◽  
pp. 1482 ◽  
Author(s):  
Leung ◽  
Chou ◽  
Huang ◽  
Yang

Aberrant overexpression of high mobility group AT-hook 2 (HMGA2) is frequently found in cancers and HMGA2 has been considered an anticancer therapeutic target. In this study, a pan-cancer genomics survey based on Cancer Cell Line Encyclopedia (CCLE) and The Cancer Genome Atlas (TCGA) data indicated that HMGA2 was mainly overexpressed in gastrointestinal cancers including colorectal cancer. Intriguingly, HMGA2 overexpression had no prognostic impacts on cancer patients’ overall and disease-free survivals. In addition, HMGA2-overexpressing colorectal cancer cell lines did not display higher susceptibility to a previously identified HMGA2 inhibitor (netroposin). By microarray profiling of HMGA2-driven gene signature and subsequent Connectivity Map (CMap) database mining, we identified that S100 calcium-binding protein A4 (S100A4) may be a druggable vulnerability for HMGA2-overexpressing colorectal cancer. A repurposing S100A4 inhibitor, niclosamide, was found to reverse the HMGA2-driven gene signature both in colorectal cancer cell lines and patients’ tissues. In vitro and in vivo experiments validated that HMGA2-overexpressing colorectal cancer cells were more sensitive to niclosamide. However, inhibition of S100A4 by siRNAs and other inhibitors was not sufficient to exert effects like niclosamide. Further RNA sequencing analysis identified that niclosamide inhibited more cell-cycle-related gene expression in HMGA2-overexpressing colorectal cancer cells, which may explain its selective anticancer effect. Together, our study repurposes an anthelminthic drug niclosamide for treating HMGA2-overexpression colorectal cancer.


2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Guang-Yuh Chiou ◽  
Tzu-Wei Yang ◽  
Chi-Chou Huang ◽  
Chia-Ying Tang ◽  
Jung-Yi Yen ◽  
...  

2020 ◽  
Author(s):  
Markus A. Brown ◽  
Gabrielle A. Dotson ◽  
Scott Ronquist ◽  
Georg Emons ◽  
Indika Rajapakse ◽  
...  

AbstractCanonical Wnt signaling is crucial for intestinal homeostasis as the major Wnt signaling effector in the intestines, TCF4, is required for stem cell maintenance. The capability of TCF4 to maintain the stem cell phenotype is contingent upon β-catenin, a potent transcriptional activator which interacts with histone acetyltransferases and chromatin remodeling complexes. In colorectal cancer, mutations result in high levels of nuclear β-catenin causing aberrant cell growth. Here, we used RNAi to explore the influence of TCF4 on chromatin structure (Hi-C) and gene expression (RNA sequencing) across a 72-hour time series in colorectal cancer. We found that TCF4 reduction results in a disproportionate upregulation of gene expression genome-wide, including a powerful induction of SOX2. Hi-C analysis revealed a general increase in chromatin compaction across the entire time series, though this did not influence gene expression. Analysis of local chromosome organization demonstrated a TAD boundary loss which influenced the expression of a cluster of CEACAM genes on chromosome 19. Four-dimensional nucleome (4DN) analysis, which integrates structural (Hi-C) and functional (RNA sequencing) data, identified EMT and E2F as the two most deregulated pathways and LUM, TMPO, and AURKA as highly influential genes in these networks. Results from gene expression, chromatin structure, and centrality analyses were then integrated to generate a list of candidate transcription factors for reprogramming of colorectal cancer cells to a vulnerable state. The top ranked transcription factor in our analysis was c-JUN, an oncoprotein known to interact with TCF4 and β-catenin.


2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 5546-5546
Author(s):  
L. Ozbun ◽  
V. Vathipadiekal ◽  
M. E. Radonovich ◽  
C. Pise-Masison ◽  
D. Saxena ◽  
...  

2010 ◽  
Vol 70 (22) ◽  
pp. 9243-9252 ◽  
Author(s):  
Nathalie Gaspar ◽  
Lynley Marshall ◽  
Lara Perryman ◽  
Dorine A. Bax ◽  
Suzanne E. Little ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document